Ole stoney has nailed a bunch of gummies in a row; is his luck about to run out? Or is here one more?
POSSIBLE GUMMY)---
Founded in 2013 by Armon Sharei (“CEO”). He invented the core CellSqueeze technology that forms the basis of SQZ Biotech out of the
Jensen and Langer Labs at MIT. The technical premise is that gentle squeezing of cells opens up temporary pores in the plasma membrane to enable non-viral, intracellular delivery of macromolecules. SQZ is applying this technology to develop new cell therapies for oncology, infectious disease, autoimmunity and chronic diseases like diabetes.
-->
SQZ Biotechnologies initiated with Buy, $17 target at Chardan 06:09 SQZ Chardan analyst Geulah…
SQZ-$3.58 up 6.8% in pre market.